Home > Partnerships

Partnerships

Anaxomics wishes to stablish long-term partnerships with consultancy firms and other companies specialized in the Discovery / Preclinical stages of Drug Development, both in Europe and in the US. We have stablished already a partnership with IRIDESSA, a Swiss Company providing drug development consulting services spanning from discovery through to early proof-of-concept studies.

Iridessa

Iredessa provides drug development consulting services spanning from discovery through to early proof-of-concept studies. We work collaboratively with clients to deliver enhanced drug development decision making with the potential for faster time to market and/or lower development costs. The primary goals of an Iredessa collaboration typically involve one or more of the following:

To optimize the design and execution of development program(s) for one or more candidate therapeutic agent(s)
To facilitate out/in-licensing discussions with potential business partners
To support ongoing interactions with regulatory authorities

Iredessa provides clinical safety consulting services focused on preclinical and phase I safety issues. Our services will help you better address and resolve preclinical and early clinical safety issues in a timely and cost effective manner. The primary deliverables of an Iredessa safety consulting engagement are:

a development strategy to optimally address the specific safety issue(s)
a related strategy to facilitate interactions with relevant regulatory authorities

For more information about IRIDESSA please contact Mr Georges Jaccard:
email: gjaccard@iridessa.ch
Tel: +41 217 995 520
Fax: +41 217 995 521